| Clint | Could you please repeat that? http://www.uberdorkcafe.com/tadavar-price.pdf tadavar 20 The drugmaker's largest shareholder, Roumell AssetManagement, said on Thursday it believed that Retrophin Inc's offer to buy Transcept at $4 per share was "woefullyinadequate," and urged the company to launch an open auctionprocess to solicit interest from additional parties. |
|